Suppr超能文献

在很大的表达范围内,皮肤银屑病基因表达的跨研究同质性。

Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.

机构信息

Medical Sciences, Amgen Inc., Seattle, WA, USA.

出版信息

PLoS One. 2013;8(1):e52242. doi: 10.1371/journal.pone.0052242. Epub 2013 Jan 4.

Abstract

BACKGROUND

In psoriasis, only limited overlap between sets of genes identified as differentially expressed (psoriatic lesional vs. psoriatic non-lesional) was found using statistical and fold-change cut-offs. To provide a framework for utilizing prior psoriasis data sets we sought to understand the consistency of those sets.

METHODOLOGY/PRINCIPAL FINDINGS: Microarray expression profiling and qRT-PCR were used to characterize gene expression in PP and PN skin from psoriasis patients. cDNA (three new data sets) and cRNA hybridization (four existing data sets) data were compared using a common analysis pipeline. Agreement between data sets was assessed using varying qualitative and quantitative cut-offs to generate a DEG list in a source data set and then using other data sets to validate the list. Concordance increased from 67% across all probe sets to over 99% across more than 10,000 probe sets when statistical filters were employed. The fold-change behavior of individual genes tended to be consistent across the multiple data sets. We found that genes with <2-fold change values were quantitatively reproducible between pairs of data-sets. In a subset of transcripts with a role in inflammation changes detected by microarray were confirmed by qRT-PCR with high concordance. For transcripts with both PN and PP levels within the microarray dynamic range, microarray and qRT-PCR were quantitatively reproducible, including minimal fold-changes in IL13, TNFSF11, and TNFRSF11B and genes with >10-fold changes in either direction such as CHRM3, IL12B and IFNG.

CONCLUSIONS/SIGNIFICANCE: Gene expression changes in psoriatic lesions were consistent across different studies, despite differences in patient selection, sample handling, and microarray platforms but between-study comparisons showed stronger agreement within than between platforms. We could use cut-offs as low as log10(ratio) = 0.1 (fold-change = 1.26), generating larger gene lists that validate on independent data sets. The reproducibility of PP signatures across data sets suggests that different sample sets can be productively compared.

摘要

背景

在银屑病中,使用统计和倍数变化截止值发现,在确定为差异表达的基因(银屑病皮损与非皮损)集合之间仅有有限的重叠。为了提供利用先前银屑病数据集的框架,我们试图了解这些集合的一致性。

方法/主要发现:使用微阵列表达谱分析和 qRT-PCR 来描述来自银屑病患者的 PP 和 PN 皮肤中的基因表达。使用共同的分析管道比较 cDNA(三个新数据集)和 cRNA 杂交(四个现有数据集)数据。使用不同的定性和定量截止值来评估数据集之间的一致性,以在源数据集生成 DEG 列表,然后使用其他数据集来验证该列表。当使用统计过滤器时,一致性从所有探针集的 67%增加到超过 10000 个探针集的 99%以上。单个基因的倍数变化行为在多个数据集之间往往是一致的。我们发现,倍数变化值<2 的基因在两个数据集之间具有定量可重复性。在微阵列检测到的炎症变化的基因亚集中,通过 qRT-PCR 高一致性地确认了微阵列检测到的变化。对于微阵列动态范围内具有 PN 和 PP 水平的转录本,微阵列和 qRT-PCR 具有定量可重复性,包括 IL13、TNFSF11 和 TNFRSF11B 的最小倍数变化,以及在任一方向上具有>10 倍变化的基因,如 CHRM3、IL12B 和 IFNG。

结论/意义:尽管在患者选择、样本处理和微阵列平台方面存在差异,但银屑病皮损中的基因表达变化在不同研究中是一致的,但研究间比较显示,在同一平台内的一致性强于平台间的一致性。我们可以使用低至 log10(ratio)=0.1(倍数变化=1.26)的截止值,生成更大的基因列表,这些列表可以在独立的数据集中验证。数据集之间 PP 特征的可重复性表明,可以有效地比较不同的样本集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb4e/3537625/64b7dd3fdcc3/pone.0052242.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验